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M A J O R A R T I C L E
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Lok-yee So,7 Yu-lung Lau,4 Kwok-hung Chan,3 Patrick C. Y. Woo,1,2,3 and Kwok-yung Yuen1,2,3
1State Key Laboratory of Emerging Infectious Diseases, 2Research Centre of Infection and Immunology, 3Department of Microbiology,
and 4Department of Pediatrics and Adolescent Medicine, Queen Mary Hospital, University of Hong Kong, 5Department of Pathology,
Tuen Mun Hospital, and Departments of 6Pathology and 7Pediatrics and Adolescent Medicine, Pamela Youde Nethersole
Eastern Hospital, Hong Kong, and 8Shenzhen East Lake Hospital, Shenzhen, China
(See the editorial commentary by Mackay, on pages 968–70.)
Background. Human bocavirus (HBoV) is a recently discovered parvovirus associated with respiratory tract
infections in children. We conducted the first systematic prospective clinical and molecular study using nasopha-
ryngeal aspirates (NPAs) and fecal samples.
Methods. NPAs negative for influenza virus, parainfluenza virus, respiratory syncytial virus, adenovirus, and
coronavirus and fecal samples from patients with acute gastroenteritis were included. On the basis of results from
a pilot study using 400 NPAs from all age groups, a prospective 12-month study was conducted to detect HBoV
in 1200 NPAs and 1435 fecal samples from patients !18 years old by polymerase chain reaction. The complete
genome sequences of HBoVs from 12 NPAs and 12 fecal samples were determined.
Results. Of the 400 NPAs collected in the pilot study, 20 (5.0%) were found to contain HBoV, all from children
!5 years old. In the subsequent prospective study of pediatric patients, HBoV was detected in 83 (6.9%) of 1200
NPAs. Upper and lower respiratory tract infections were equally common. HBoV was detected in 30 (2.1%) of
1435 fecal samples. Fever and watery diarrhea were the most common symptoms. The seasonality of HBoV in
NPAs and fecal samples was similar. Codetection with other pathogens occurred in 33% and 56% of NPAs and
fecal samples, respectively, from patients with HBoV infection. Genomes of HBoVs from NPAs and fecal samples
displayed minimal sequence variations.
Conclusions. HBoV was detected in fecal specimens in children with acute gastroenteritis. A single lineage of
HBoV was associated with both respiratory tract and enteric infections.
Because a substantial proportion of respiratory tract
infections remain undiagnosed [1, 2], research has been
conducted to identify novel causative agents. Over the
past few years, several novel respiratory viruses—in-
cluding human metapneumovirus (hMPV) [3], severe
acute respiratory syndrome (SARS) coronavirus (SARS-
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CoV) [4], human coronavirus NL63 (HCoV-NL63) [5,
6], and coronavirus HKU1 (CoV-HKU1) [7–10]—have
been identified.
In 2005, Allander et al. [11] reported the discovery
of a previously undescribed human parvovirus in re-
spiratory secretions from children with respiratory tract
disease in Sweden. Phylogenetic analysis showed that
this virus belonged to the genus Bocavirus (subfamily,
Parvovirinae; family, Parvoviridae) and was most
closely related to bovine parvovirus (BP) and minute
virus of canines (MVC). The virus was thus named
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“human bocavirus” (HBoV). By a specific polymerase chain
reaction (PCR) assay, the virus was found to be present in 17
(3.1%) of 540 respiratory specimens collected from hospitalized
children over a 1-year period [11].
Subsequently, HBoV has been reported in respiratory sam-
ples from children in various parts of the world (including
Australia, North America, Europe, Asia, and Africa), suggesting
that the virus is circulating worldwide [12–24]. Among these
studies, HBoV was detected in 1.5%–18.3% of respiratory sam-
ples from individuals with acute respiratory tract illness, es-
pecially those from young children and infants. Despite these
findings, the clinical spectrum of disease and a causative role
for this novel virus remain to be ascertained. In a recent study,
HBoV DNA was found to be frequently present in serum sam-
ples from patients with acute wheezing, suggesting that the virus
may be associated with systemic infection [25]. However, it is
not known whether HBoV is associated with nonrespiratory
tract illness and can be detected in other clinical specimens.
Moreover, few studies to date have included specimens from
older children or adults.
To assess the epidemiology of HBoV infection in our pop-
ulation, in a pilot study we examined the prevalence of HBoV
in randomly selected nasopharyngeal aspirates (NPAs) from
hospitalized patients of all ages. On the basis of the results of
this pilot study, a 1-year prospective study was conducted using
NPAs and fecal samples from pediatric patients to determine
clinical disease associations and the epidemiology of HBoV
infection in children in Hong Kong. The molecular epidemi-
ology of HBoV detected in NPAs and fecal samples was also
analyzed.
METHODS
Patients and microbiological methods. All samples were col-
lected from hospitalized patients at 3 hospitals in Hong Kong.
All NPAs were tested for influenza viruses A and B; parain-
fluenza viruses 1, 2, and 3; respiratory syncytial virus; and
adenovirus by direct immunofluorescence. NPAs were also
tested for human coronavirus 229E, human coronavirus OC43,
HCoV-NL63, and CoV-HKU1 by reverse-transcription PCR
(RT-PCR) [9, 10, 26]. As a pilot study to determine the age
distribution of HBoV infection in our population, 200 NPAs
negative for the respiratory viruses listed above (118 from pe-
diatric patients [!18 years old] and 92 from adult patients [18
years old]) and 200 NPAs positive for any of these viruses (166
from pediatric patients and 34 from adult patients) sent to the
microbiology laboratories were randomly selected for HBoV
testing by PCR.
Because all positive samples from the pilot study were from
young children, a prospective study that aimed to determine
the epidemiology of HBoV infection and the clinical spectrum
of disease caused by this infection was done using specimens
from pediatric patients during a 12-month period (November
2004–October 2005). One hundred NPAs from pediatric pa-
tients that tested negative for the respiratory viruses listed above
were randomly selected each month for HBoV testing by PCR.
During the same period, fecal samples were also collected from
pediatric patients with acute gastroenteritis, which was defined
as the development of acute diarrhea with 3 or more loose
stools per day. All fecal samples were tested for common bac-
terial diarrheal pathogens, rotavirus (by antigen detection [27]),
and HBoV (by PCR). When HBoV was detected, the corre-
sponding patients were identified, and their clinical features,
laboratory results, and outcome were analyzed retrospectively.
PCR for HBoV and sequencing. DNA from NPAs and fecal
samples was extracted using the QIAamp DNA Mini Kit (Qia-
gen), in accordance with the manufacturer’s protocol. DNA
was subjected to PCR for HBoV as described elsewhere, using
forward primer 5′-GAGCTCTGTAAGTACTATTAC-3′ and re-
verse primer 5′-CTCTGTGTTGACTGAATACAG-3′ targeted to
a 354-bp fragment of the NP1 gene; the primers were based
on the corrected sequences published as a corrigendum [11].
The amplified products were detected by agarose gel electro-
phoresis. Both strands of all PCR products were sequenced
twice with an ABI Prism 3700 DNA Analyzer (Applied Bio-
systems), using the PCR primers. The sequences of the PCR
products were compared with the sequences of HBoV strains
available in GenBank.
Detection of hMPV and rhinovirus by RT-PCR. There was
no significant difference in the rate of detection of HBoV be-
tween NPAs that were positive and those that were negative for
other respiratory viruses, which raised the possibility that con-
comitant respiratory viruses that were not included in our tests
may also be present in the NPAs. Therefore, stored RNA from
all NPAs positive for HBoV was retrieved and subjected to RT-
PCR for hMPV and rhinovirus. Viral RNA was extracted from
NPAs by use of the QIAamp Viral RNA Mini Kit (Qiagen). RT
was performed using random hexamers and the SuperScript II
Kit (Invitrogen) [7, 8]. PCR for hMPV and rhinoviruses was
performed using protocols described elsewhere [28, 29].
Complete genome sequencing and phylogenetic analysis of
the NS1, NP1, and VP1/VP2 genes of HBoV. The complete
genomes of HBoVs from 12 NPAs and 12 fecal samples were
amplified and sequenced using a strategy that has been de-
scribed elsewhere [8]. Primers were designed by multiple align-
ment of the genomes of HBoV available in GenBank, and ad-
ditional primers were designed on the basis of the results of
the first and subsequent rounds of sequencing. The terminal
sequences were confirmed by a modified protocol for rapid
amplification of cDNA ends [11]. However, these terminal se-
quences may be incomplete because of their hairpin structures.
The nucleotide and the deduced amino acid sequences of the
NS1, NP1, and VP1/VP2 genes were compared with those of
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Figure 1. Seasonality of human bocavirus (HBoV) in nasopharyngeal aspirates (NPAs) and fecal samples (A) and distribution of HBoV-positive children
by age (B).
HBoV strains with a complete genome sequence available in
GenBank. Phylogenetic trees were constructed by the neighbor-
joining method with GrowTree, using Kimura’s 2-parameter
correction with ClustalX 1.83 (Genetics Computer Group).
Nucleotide sequence accession numbers. The complete
genome sequences of the 24 strains of HBoV identified here
have been deposited in GenBank under accession numbers
EF450717–EF450740.
RESULTS
Detection of HBoV in NPAs from pediatric patients. Of the
200 NPAs that were negative for influenza A and B viruses;
parainfluenza viruses types 1, 2, and 3; respiratory syncytial
virus; adenovirus; and the 4 human coronaviruses, 7 (3.5%)
were positive for HBoV. Of the 200 NPAs that were positive
for any of these respiratory viruses, 13 (6.5%) were positive for
HBoV. All of the 20 HBoV-positive NPAs were from children
!5 years old. The detection rate in pediatric patients (!18 years
old; 20/284 [7%]) was significantly higher than that in adults
(18 years old; 0/126 [0%]) ( , x2 test). Therefore, theP ! .005
subsequent prospective study was conducted in pediatric
patients.
During the 12-month prospective study period, 1200 NPAs
(100 per month) from pediatric patients (male to female ratio,
1.6:1; age, years) were subjected to PCRmean SD 3.8 3.9
for HBoV. HBoV was detected in 83 NPAs. These 83 NPAs
were obtained from 79 patients who were !10 years old (median
age, 2 years; range, 6 months–9 years). Since 1081 of the 1200
NPAs were obtained from patients !10 years old, the 83 positive
NPAs represent a 7.7% (83/1081) detection rate in this pop-
ulation. Of the 79 patients positive for HBoV, 46 were male,
and 33 were female. HBoV was detected throughout the year,
with the highest prevalence during fall and winter (figure 1).
Of the 79 patients, 36 had received a clinical diagnosis of
upper respiratory tract infection (URTI), and 35 had a lower
respiratory tract infection (LRTI). The remaining 8 patients did
not have respiratory symptoms (table 1). Of the 35 patients
with LRTI, 27 had pneumonia, 6 had acute bronchitis/bron-
chiolitis, and 2 had croup. One patient with pneumonia had
Streptococcus pneumoniae isolated from the sputum. Although
fever, cough, and rhinorrhea were the most common symptoms
in patients with URTI, 2 had acute pharyngitis (with b-he-
molytic group A streptococcus isolated from a throat swab in
one of them), and 1 patient had acute sinusitis. Three patients
with URTI and 3 with LRTI also had acute nonsuppurative
otitis media. Fourteen patients experienced an asthma exac-
erbation, with 1 complicated by status asthmaticus. A number
of patients with acute respiratory illness also had nonrespiratory
symptoms or additional diagnoses. Nine had febrile convulsion,
and 2 others with underlying epilepsy had breakthrough sei-
zures. Six had symptoms of gastroenteritis, and 1 had intus-
susception. One had pneumonia and gastroenteritis compli-
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Table 1. Clinical characteristics of the patients with human bo-
cavirus (HBoV) detected in nasopharyngeal aspirates.
Characteristic Value
Patients, total no. 79
Male to female ratio 46:33
Age, median (range) 2 years (6
months–9 years)
Diagnosisa
URTI 36 (46)
Acute pharyngitis 2 (3)
Acute sinusitis 1 (1)
Acute otitis media 6 (8)
Acute bronchitis/bronchiolitis 6 (8)
Pneumonia 27 (34)
Croup 2 (3)
Asthma exacerbation 14 (18)
Febrile convulsion 9 (11)
Breakthrough seizure 2 (3)
Aseptic meningitis 1 (1)
Gastroenteritis 9 (11)
Acute hepatitis 1 (1)
Intussusception 1 (1)
Kawasaki disease 2 (3)
Infectious mononucleosis 2 (3)
Herpangina 1 (1)
Herpetic gingivostomatitis 2 (3)
Henoch-Scho¨nlein purpura 1 (1)
Roseola infantum 1 (1)
Nephrotic syndrome 1 (1)
Copathogens
Streptococcus pyogenes 1 (1)
Streptococcus pneumoniae 1 (1)
Enterovirus 2 (3)
Epstein-Barr virus 2 (3)
Rotavirus 2 (3)
Herpes simplex virus 2 (3)
Rhinovirus 14 (18)
Human metapneumovirus 2 (3)
NOTE. Data are no. (%) of patients, unless otherwise indicated. URTI,
upper respiratory tract infection.
a Percentages sum to 1100% because some patients had 11 diagnosis.
Table 2. Summary of characteristics of the patients with human
bocavirus detected in fecal samples.
Characteristic Value
Patients, total no. 25
Male to female ratio 18:7
Age, median (range) 17 months (2
months–3 years)
Clinical manifestations/other diagnosesa
Presence of blood in stool 4 (16)
Presence of mucus in stool 2 (8)
Vomiting 8 (32)
Fever 17 (68)
Coryzal symptoms 14 (56)
Acute bronchiolitis 4 (16)
Pneumonia 3 (12)
Febrile convulsion 2 (8)
Breakthrough seizure 1 (4)
Urinary tract infection 1 (4)
Copathogens
Rotavirus 9 (36)
Salmonella species 2 (8)
Campylobacter species 1 (4)
Staphylococcus aureus 1 (4)
Clostridium difficile 1 (4)
NOTE. Data are no. (%) of patients, unless otherwise indicated.
a Percentages sum to 1100% because some patients had 11 diagnosis.
cated by nephrotic syndrome. Two others with pneumonia had
primary Epstein-Barr virus infection. One patient with URTI
had herpangina, 2 had herpetic gingivostomatitis, and another
had Henoch-Scho¨nlein purpura. Of the 8 patients without re-
spiratory symptoms, 3 had gastroenteritis, 2 of whom had ro-
tavirus antigen detected in their fecal samples. Two had Ka-
wasaki disease. One had aseptic meningitis due to enterovirus.
One had acute hepatitis of unknown etiology. One had roseola
infantum. Interestingly, HBoV was persistently detected in a 2-
year-old boy in 5 separate NPAs collected over a 1-month pe-
riod. Apart from the HBoV infection in this patient, who had
URTI complicated by recurrent wheezing during his prolonged
hospitalization for short gut syndrome, all cases were com-
munity acquired. All 79 patients survived.
Detection of HBoV in fecal samples from pediatric patients
with acute gastroenteritis. During the 12-month period, 1435
fecal samples from pediatric patients with acute gastroenteritis
(male to female ratio, 1.6:1; age, years)mean SD 2.7 3.4
were subjected to PCR for HBoV. HBoV was detected in 30
samples (2.1%) from 25 patients (tables 2 and 3). The median
age of these patients was 17 months (range, 2 months–3 years).
Eighteen were male and seven were female. As with the results
for NPAs, HBoV was mainly detected in fecal samples during
the fall and winter months, with all cases occurring from Sep-
tember to February. Diarrhea lasted for 1–4 days, and the fre-
quency of stool passage ranged from 3–20 times per day. Blood
was present in the stool of 4 patients and in the mucus of 2.
Eight experienced vomiting, and 17 had fever. Coryzal symp-
toms occurred in 14 patients. Seven had LRTI, with pneumonia
in 3 and acute bronchiolitis in 4. One also had urinary tract
infection. Two had febrile convulsions, and 1 with underlying
epilepsy had recurrent seizures. Diarrheal pathogens were fre-
quently found in fecal samples, with rotavirus identified in 9,
serogroup B Salmonella species in 2, Campylobacter species in
1, and Staphylococcus aureus in 1. HBoV was repeatedly detected
in separate fecal samples from 3 patients. In particular, HBoV
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Table 3. Clinical characteristics of the 25 patients with human bocavirus detected in fecal samples.
Patient
Month of
detection Sex Age Underlying disease
Diagnosis other than
gastroenteritis
Codetection in
fecal sample
Multiple
detection
(days apart)
1 Nov Male 2 years Autism None None ND
2 Nov Male 16 months None None Rotavirus ND
3 Nov Male 2 months None Acute bronchiolitis None ND
4 Nov Male 13 months None Pneumonia None ND
5 Nov Male 3 years None None Campylobacter ND
6 Dec Male 7 months Sacral mass None None ND
7 Dec Female 19 months None Pneumonia None ND
8 Dec Male 20 months Febrile convulsion Febrile convulsion Rotavirus ND
9 Dec Male 4 months History of urinary tract infection Urinary tract infection None ND
10 Dec Male 8 months None Acute bronchiolitis None ND
11 Dec Male 16 months None None Rotavirus ND
12 Dec Female 16 months Epilepsy Breakthrough seizures Rotavirus ND
13 Dec Male 5 months History of urinary tract infection None Serogroup B Salmonella ND
14 Dec Male 20 months None None Rotavirus ND
15 Jan Female 9 months Ring chromosome 18,
congenital heart disease, hydrocephalus
None None ND
16 Jan Female 3 years Nephrotic syndrome Pneumonia Rotavirus Yes (3)
17 Jan Male 3 years Smith-Lemli-Opitz syndrome, myelodys-
plastic syndrome
Acute bronchiolitis Clostridium difficile Yes (35)
18 Jan Male 18 months Febrile convulsion Febrile convulsion None ND
19 Jan Male 3 months None None Rotavirus, Staphylococ-
cus aureus
ND
20 Jan Female 2 years Febrile convulsion None Rotavirus ND
21 Jan Male 2 years Short gut syndrome, chronic lung disease None None Yes (2)
22 Jan Male 7 months None Acute bronchiolitis Rotavirus ND
23 Sep Male 18 months None None Serogroup B Salmonella ND
24 Oct Female 19 months B cell immunodeficiency None None ND
25 Oct Female 5 months None None None ND
NOTE. ND, not done.
was persistently found in 4 samples collected over 5 weeks from
a 3-year-old boy (patient 17 in table 3) with multiple congenital
malformations who developed persistent diarrhea due to Clos-
tridium difficile during hospitalization. Apart from the HBoV
infection in this patient, all cases were community acquired.
All patients survived.
Detection of hMPV and rhinovirus in NPAs. Available
RNA from 93 NPAs positive for HBoV was subject to RT-PCR
for hMPV and rhinovirus. Of these 93 samples, 14 were positive
for rhinovirus, and 2 were positive for hMPV. Rhinovirus was
detected in 6 with LRTI and 8 with URTI. Ten of these 14
patients with rhinovirus infection had asthma exacerbations,
and 2 had febrile convulsions. hMPV was detected in 1 patient
with LRTI and in 1 patient with URTI and gastroenteritis.
Complete genome sequencing and phylogenetic analysis of
the NS1, NP1, and VP1/VP2 genes of HBoV. The complete
genomes of HBoVs from 12 NPAs and 12 fecal samples were
amplified and sequenced. The 24 HBoV genomes (size, 5.2 kb)
had G+C content of 42%. The genomic organization was the
same as that of the 2 prototype HBoV strains, ST1 and ST2,
and of other known bocaviruses, BPV and MVC. There were
3 open reading frames (ORFs), with the gene order NS1, NP1,
and VP1/VP2. Sequence analysis showed that the 24 strains of
HBoV displayed limited sequence variations among themselves
as well as in relation to the available sequences of previously
described HBoV strains in all 3 genes (figure 2). The NS1 gene
was the most conserved gene among the 3, with only minor
nucleotide polymorphisms. The predicted amino acid se-
quences of the NS1 gene of the 24 HBoV strains were identical
among themselves and in relation to NS1 sequences of HBoVs
from GenBank, except for a strain from China (HBoV_WLL-
1) that had 1 amino acid substitution (HisrArg) resulting from
a mutation at nucleotide position 1328. The greatest sequence
variations occurred in the VP1/VP2 gene, although the overall
nucleotide and amino acid differences among different strains
were !2% and !1%, respectively.
DISCUSSION
Although the results of this study of NPAs are similar to those
of previous studies, the present report is the first to document
the presence of HBoV in fecal specimens. In this 1-year pro-
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Figure 2. Phylogenetic trees of complete NS1, NP1, and VP1/VP2 gene sequences of 12 human bocavirus (HBoV) strains from nasopharyngeal
aspirates (NPAs) and 12 HBoV strains from fecal samples. The trees were inferred from NS1 (A), NP1 (B), and VP1/VP2 (C) gene data by the
neighbor-joining method, using bootstrap values calculated from 1000 trees. The trees were rooted using the NS1, NP1, and VP1/VP2 gene
sequences of minute virus of canine; 1920 nucleotide positions in each NS1 gene, 660 nucleotide positions in each NP1 gene, and 2016 nucleotide
positions in each VP1/VP2 gene were included in the analysis. The scale bar indicates the estimated no. of substitutions per 500 bases by Kimura’s
2-parameter model. HBoV strains ST1 and ST2, from Sweden, were the 2 prototype strains. Strains WLL-1 and CZ643 are from China, and strain
CRD2 is from the United States.
spective study, HBoV was found in NPAs from 79 children, 71
of whom had acute respiratory tract illness. Similar to previous
studies, most of our patients with HBoV infection were infants
or young children. Although on occasion adults have been
reported to be infected with HBoV [22, 30], none of the NPAs
from adults in the present study was positive for HBoV. Among
patients with acute respiratory tract illness, URTI and LRTI
were equally common. Although asthma exacerbations, febrile
convulsions, and gastroenteritis were common associated clin-
ical manifestations, other apparently unrelated diagnoses were
also frequent. Among those patients without respiratory symp-
toms but with HBoV detected in NPAs, gastroenteritis was the
most common diagnosis, in agreement with the detection of
HBoV in fecal samples from children with gastroenteritis. In a
previous study in the United States, it was found that 5 HBoV-
positive children had diarrhea [14]. However, it was not known
whether HBoV could be detected in their fecal samples. In the
present study, HBoV was detected in 2.1% of fecal samples
from children with gastroenteritis. Fever and watery diarrhea
were the most common manifestations, followed by coryzal
symptoms and vomiting. Similar to findings for NPAs, the
affected children were young (3 years of age). The seasonal
epidemiological profile of HBoV in fecal samples was similar
to that in NPAs, with the highest incidence in fall and winter.
The finding of HBoV in both respiratory and enteric specimens
from humans concurs with the characteristics of the other 2
members of the genus Bocavirus, BP and MVC. BP causes
diarrhea and mild respiratory symptoms in calves [31, 32].
Although MVC is associated with fetal infections and neona-
tal respiratory disease in dogs, the virus has occasionally been
associated with enteritis [33, 34]. Further studies are required
to determine the role played by HBoV in enteric disease in
humans.
Although there is no doubt that HBoV is a common human
virus acquired early during life, the causative role of HBoV in
human disease remains to be determined. Despite the large
number of studies of HBoV conducted, it was not until recently
that a control group of asymptomatic children was included.
In this study from the United States, HBoV was identified in
22 (5.2%) of 425 samples from symptomatic children but in
none from the asymptomatic control children ( ) [14],Pp .02
supporting an association between HBoV and respiratory tract
illness. However, although respiratory specimens from their
symptomatic children included nasal swabs, respiratory secre-
tions, and bronchoalveolar lavage fluid sent to a hospital-based
laboratory, only nasal wash specimens were obtained from
992 • JID 2007:196 (1 October) • Lau et al.
asymptomatic control children at a primary care center. Because
it was not indicated whether any of the HBoV-positive speci-
mens were nasal washes, it is difficult to conclude whether the
observed difference was genuine or due to discrepancies in
sampling. Nevertheless, in another study, HBoV also appeared
to be more common among individuals with respiratory tract
disease than among those without symptoms [15]. Although
the association between HBoV and respiratory tract disease may
support a role for the virus in pathogenesis, it does not prove
causality, which is often difficult to ascertain in the case of
respiratory viruses [35].
Although a lack of proof of causality by Koch’s postulates
does not exclude the possibility that HBoV is a pathogen, its
exceptionally high frequency of codetection with other respi-
ratory viruses, a phenomenon that was not observed for known
respiratory viruses, has led to reservations concerning its role
in human disease. The frequency of codetection in HBoV-pos-
itive respiratory samples has ranged from 33% to 80%, de-
pending on how intensively other respiratory viruses were
sought, the sensitivities of the methods used, and the sampling
size [12, 16–21]. The highest codetection rate—observed in a
Swiss study in which 4 of 5 HBoV-positive nasal samples from
infants contained other respiratory viruses—may have been due
to the inclusion of a comprehensive panel of respiratory viruses
that included rhinovirus and coronaviruses [16]. In the present
study, although many common respiratory viruses were initially
excluded from the NPAs selected for HBoV testing, 33% of the
patients with NPAs positive for HBoV were subsequently found
to have coinfections with another pathogen. As for fecal sam-
ples, a high rate of coinfection (56%) was also observed. It has
been reported that the frequency of HBoV infection was even
higher when another virus was present [15]. In the present
study, a higher prevalence was also observed in NPAs positive
for common respiratory viruses (6.5%) than in those that were
negative (3.5%). Further studies are required to determine
whether HBoV plays a causative role in these coinfections or
acts as an exacerbating factor that simply increases the severity
of infections caused by other pathogens.
The low genetic diversity of HBoV suggested that a single
lineage was responsible for both respiratory tract and enteric
infections in humans. This is in contrast to coronaviruses,
which have different genotypes, possibly as a result of a high
frequency of recombination [36]. The 5.2-kb genome of HBoV
contains 3 ORFs encoding NS1 (a nonstructural protein), NP1
(a protein of unknown function), and VP1/VP2 (viral capsid
protein). Phylogenetic analysis of these 3 ORFs in all 24 HBoV
strains from NPAs and fecal samples did not reveal a genotypic
difference between the strains from NPAs and those from fecal
samples. Among the 3 genes, NS1 appeared to be the most
conserved. Similar to the findings of previous studies, which
mostly examined the partial NP1 gene, minor nucleotide sub-
stitutions were observed in NP1, with occasional amino acid
substitutions. When HBoV was first described, it was found
that most nucleotide polymorphisms occurred in VP1/VP2
[11]. Only 2 subsequent studies have analyzed partial se-
quences of VP1/VP2. In one study, which involved the se-
quencing of a 1-kb fragment of the VP2 gene, 97.5%–100%
nucleotide sequence identity was observed between their HBoV
strains and the prototype strains, suggesting a unique lineage
of HBoV [18]. In another study, which analyzed the 3′ 819-bp
fragment of VP1/VP2, the authors suggested that 2 distinct
genotypes were observed, with ST1 being in one cluster and
ST2 in another [14]. In the present study, comparison of the
complete VP1/VP2 gene sequences from our 24 HBoV strains
and strains from other countries showed only minor variations.
Although phylogenetic analysis of this gene showed that there
may be clustering among some strains, the existence of distinct
genotypes cannot be concluded. In fact, our present results
suggest that humans are infected by a single lineage of HBoV,
which was detected in both respiratory tract and enteric
samples.
The lack of variation in the surface protein of HBoV suggests
that HBoV infection may happen only once, with the subse-
quent development of life-long immunity via neutralizing an-
tibody. This is consistent with the fact that HBoV infection
occurs primarily in infants and young children. The develop-
ment of immunity against HBoV and the clearance of HBoV
may depend on the integrity of one’s immune system. In the
Swiss study [16], HBoV was detected in follow-up samples from
only 1 of the 5 infants, suggesting that HBoV is rapidly cleared
in most cases. In the present study, persistent HBoV shedding
for 11 month was observed in both respiratory tract and fe-
cal specimens from patients with significant underlying dis-
eases, which may represent prolonged infections as a result of
underlying immunosuppression. However, routine follow-up
was not done in our patients, because our clinical data were
mainly collected retrospectively after HBoV PCR results had
become available, by which time most patients had been dis-
charged. Larger longitudinal studies should be conducted to
examine the duration of HBoV shedding and the mechanism
of immunity.
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